Read the story behind the quarter.
Income statement, balance sheet, and cash flow—connected to the customer situation, marketing choices, operating indicators, and real competitive alternatives.
Five reports to start with
Medtronic FY2026 Earnings: How turning clinical evidence, access, adherence, and professional trust shaped growth and margin
Medtronic reported $36.4B in revenue and $6.5B in operating profit for FY2026. We connect the customer situation and business mechanism to the income statement, balance sheet, and cash flow.
Read earnings analysis →FY2026 · STESTERIS FY2026 Earnings: How turning clinical evidence, access, adherence, and professional trust shaped growth and margin
STERIS reported $5.9B in revenue and $1.1B in operating profit for FY2026. We connect the customer situation and business mechanism to the income statement, balance sheet, and cash flow.
Read earnings analysis →FY2026 · CRVLCorVel FY2026 Earnings: How turning clinical evidence, access, adherence, and professional trust shaped growth and margin
CorVel reported $959M in revenue and $110M in operating profit for FY2026. We connect the customer situation and business mechanism to the income statement, balance sheet, and cash flow.
Read earnings analysis →FY2026 · HAEHaemonetics FY2026 Earnings: How turning clinical evidence, access, adherence, and professional trust shaped growth and margin
Haemonetics reported $1.3B in revenue and $157M in operating profit for FY2026. We connect the customer situation and business mechanism to the income statement, balance sheet, and cash flow.
Read earnings analysis →FY2026 · DOCSDoximity FY2026 Earnings: How turning clinical evidence, access, adherence, and professional trust shaped growth and margin
Doximity reported $645M in revenue and $215M in operating profit for FY2026. We connect the customer situation and business mechanism to the income statement, balance sheet, and cash flow.
Read earnings analysis →121 earnings analyses
Primary sources · US GAAP · USD millions
Medtronic FY2026 Earnings: How turning clinical evidence, access, adherence, and professional trust shaped growth and margin
Medtronic reported $36.4B in revenue and $6.5B in operating profit for FY2026. We connect the customer situation and business mechanism to the income statement, balance sheet, and cash flow.
Read earnings analysis →FY2026 · STESTERIS FY2026 Earnings: How turning clinical evidence, access, adherence, and professional trust shaped growth and margin
STERIS reported $5.9B in revenue and $1.1B in operating profit for FY2026. We connect the customer situation and business mechanism to the income statement, balance sheet, and cash flow.
Read earnings analysis →FY2026 · CRVLCorVel FY2026 Earnings: How turning clinical evidence, access, adherence, and professional trust shaped growth and margin
CorVel reported $959M in revenue and $110M in operating profit for FY2026. We connect the customer situation and business mechanism to the income statement, balance sheet, and cash flow.
Read earnings analysis →FY2026 · HAEHaemonetics FY2026 Earnings: How turning clinical evidence, access, adherence, and professional trust shaped growth and margin
Haemonetics reported $1.3B in revenue and $157M in operating profit for FY2026. We connect the customer situation and business mechanism to the income statement, balance sheet, and cash flow.
Read earnings analysis →FY2026 · DOCSDoximity FY2026 Earnings: How turning clinical evidence, access, adherence, and professional trust shaped growth and margin
Doximity reported $645M in revenue and $215M in operating profit for FY2026. We connect the customer situation and business mechanism to the income statement, balance sheet, and cash flow.
Read earnings analysis →FY2026 · MCKMcKesson FY2026 Earnings: How turning clinical evidence, access, adherence, and professional trust shaped growth and margin
McKesson reported $403.4B in revenue and $6.2B in operating profit for FY2026. We connect the customer situation and business mechanism to the income statement, balance sheet, and cash flow.
Read earnings analysis →FY2026 · HQYHealthEquity FY2026 Earnings: How turning clinical evidence, access, adherence, and professional trust shaped growth and margin
HealthEquity reported $1.3B in revenue and $322M in operating profit for FY2026. We connect the customer situation and business mechanism to the income statement, balance sheet, and cash flow.
Read earnings analysis →FY2025 · TALKTalkspace FY2025 Earnings: How turning clinical evidence, access, adherence, and professional trust shaped growth and margin
Talkspace reported $229M in revenue and $3M in operating profit for FY2025. We connect the customer situation and business mechanism to the income statement, balance sheet, and cash flow.
Read earnings analysis →FY2025 · HCATHealth Catalyst FY2025 Earnings: How turning clinical evidence, access, adherence, and professional trust shaped growth and margin
Health Catalyst reported $311M in revenue and -$161M in operating profit for FY2025. We connect the customer situation and business mechanism to the income statement, balance sheet, and cash flow.
Read earnings analysis →FY2025 · UNHUnitedHealth Group FY2025 Earnings: How turning clinical evidence, access, adherence, and professional trust shaped growth and margin
UnitedHealth Group reported $447.6B in revenue and $19B in operating profit for FY2025. We connect the customer situation and business mechanism to the income statement, balance sheet, and cash flow.
Read earnings analysis →FY2025 · SRPTSarepta Therapeutics FY2025 Earnings: How turning clinical evidence, access, adherence, and professional trust shaped growth and margin
Sarepta Therapeutics reported $2.2B in revenue and -$700M in operating profit for FY2025. We connect the customer situation and business mechanism to the income statement, balance sheet, and cash flow.
Read earnings analysis →FY2025 · RDNTRadNet FY2025 Earnings: How turning clinical evidence, access, adherence, and professional trust shaped growth and margin
RadNet reported $2B in revenue and $62M in operating profit for FY2025. We connect the customer situation and business mechanism to the income statement, balance sheet, and cash flow.
Read earnings analysis →FY2025 · ALGNAlign Technology FY2025 Earnings: How turning clinical evidence, access, adherence, and professional trust shaped growth and margin
Align Technology reported $4B in revenue and $546M in operating profit for FY2025. We connect the customer situation and business mechanism to the income statement, balance sheet, and cash flow.
Read earnings analysis →FY2025 · CHEChemed FY2025 Earnings: How turning clinical evidence, access, adherence, and professional trust shaped growth and margin
Chemed reported $2.5B in revenue and $338M in operating profit for FY2025. We connect the customer situation and business mechanism to the income statement, balance sheet, and cash flow.
Read earnings analysis →FY2025 · NTRANatera FY2025 Earnings: How turning clinical evidence, access, adherence, and professional trust shaped growth and margin
Natera reported $2.3B in revenue and -$310M in operating profit for FY2025. We connect the customer situation and business mechanism to the income statement, balance sheet, and cash flow.
Read earnings analysis →FY2025 · INGNInogen FY2025 Earnings: How turning clinical evidence, access, adherence, and professional trust shaped growth and margin
Inogen reported $349M in revenue and -$30M in operating profit for FY2025. We connect the customer situation and business mechanism to the income statement, balance sheet, and cash flow.
Read earnings analysis →FY2025 · PRVAPrivia Health FY2025 Earnings: How turning clinical evidence, access, adherence, and professional trust shaped growth and margin
Privia Health reported $2.1B in revenue and $34M in operating profit for FY2025. We connect the customer situation and business mechanism to the income statement, balance sheet, and cash flow.
Read earnings analysis →FY2025 · USPHU.S. Physical Therapy FY2025 Earnings: How turning clinical evidence, access, adherence, and professional trust shaped growth and margin
U.S. Physical Therapy reported $781M in revenue and $87M in operating profit for FY2025. We connect the customer situation and business mechanism to the income statement, balance sheet, and cash flow.
Read earnings analysis →FY2025 · PGNYProgyny FY2025 Earnings: How turning clinical evidence, access, adherence, and professional trust shaped growth and margin
Progyny reported $1.3B in revenue and $85M in operating profit for FY2025. We connect the customer situation and business mechanism to the income statement, balance sheet, and cash flow.
Read earnings analysis →FY2025 · BRKRBruker FY2025 Earnings: How turning clinical evidence, access, adherence, and professional trust shaped growth and margin
Bruker reported $3.4B in revenue and $68M in operating profit for FY2025. We connect the customer situation and business mechanism to the income statement, balance sheet, and cash flow.
Read earnings analysis →FY2025 · TMOThermo Fisher Scientific FY2025 Earnings: How turning clinical evidence, access, adherence, and professional trust shaped growth and margin
Thermo Fisher Scientific reported $44.6B in revenue and $7.7B in operating profit for FY2025. We connect the customer situation and business mechanism to the income statement, balance sheet, and cash flow.
Read earnings analysis →FY2025 · PFEPfizer FY2025 Earnings: How turning clinical evidence, access, adherence, and professional trust shaped growth and margin
Pfizer reported $62.6B in revenue and $7.5B in operating profit for FY2025. We connect the customer situation and business mechanism to the income statement, balance sheet, and cash flow.
Read earnings analysis →FY2025 · CIThe Cigna Group FY2025 Earnings: How turning clinical evidence, access, adherence, and professional trust shaped growth and margin
The Cigna Group reported $274.9B in revenue and $9.2B in operating profit for FY2025. We connect the customer situation and business mechanism to the income statement, balance sheet, and cash flow.
Read earnings analysis →FY2025 · DGXQuest Diagnostics FY2025 Earnings: How turning clinical evidence, access, adherence, and professional trust shaped growth and margin
Quest Diagnostics reported $11B in revenue and $1.6B in operating profit for FY2025. We connect the customer situation and business mechanism to the income statement, balance sheet, and cash flow.
Read earnings analysis →
